Ticker Launch

SPAC · Merger completed

Blue Water Acquisition Corp.

Business combination with Clarus Therapeutics, Inc.

Blue Water Acquisition Corp. is a blank-check company (SPAC) that raised $50M in its initial public offering on Dec 16, 2020, listing on NYSE. It completed its business combination with Clarus Therapeutics, Inc. on Sep 9, 2021; the combined company is Clarus Therapeutics Holdings, Inc. (CRXT). Ellenoff Grossman & Schole advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

Status
Merger completed
IPO date
Dec 16, 2020
IPO size
$50M
IPO exchange
NYSE
Target
Clarus Therapeutics, Inc.
Announced
May 3, 2021
Closed
Sep 9, 2021
Combined company
Clarus Therapeutics Holdings, Inc. (CRXT)
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021